Heres the FDAs stance in a nutshell: Compounded drugs are permitted when there is a bona fide shortage of the FDA-approved versions, and only under specific conditions, such as when the dosages or products are not commercially available, or for particular indications unique to an individual patient
But few, if any, prove their hype or are supported by real science
The infected mice exhibited a higher increase in interleukin (IL) IL-5, IL-4, and IL-2 than IL-12 and interferon- (IFN-), suggesting an important alteration in cytokine profile from Th1 to Th2 (Figure 2) [38]
When the FDA does crack down, its often because problems have emerged
Hydrapharm's Unbreakable not only contains BPC-157 but also includes Cissus quadrangularis and Andrographis paniculata (andrographolide)